IP Library › Granted Patent US 10,376,463
Granted Patent B2
US 10,376,463 · App. 13/469,481 · Granted Aug 13, 2019

Ocular iontophoretic delivery of dexamethasone and formulations thereof

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,376,463
App. No.
13/469,481
Granted
Aug 13, 2019
Kind
B2
Abstract

Disclosed herein are formulations of dexamethasone or a prodrug thereof suitable for delivery by ocular iontophoresis and methods of use thereof.

Claims (1)

1. An aqueous dexamethasone phosphate formulation comprising: (1) dexamethasone phosphate at a concentration of 40 mg/mL; and (ii) a buffering agent, wherein said buffering agent adjusts the pH of said formulation to 5.7 to 5.8.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 24, 2012
From: JAFFE, MIKE; COOK, GARY; CALIAS, PERRY; PATANE, MICHAEL A.
To: EYEGATE PHARMACEUTICALS, INC.
Reel/Frame 028264/0617 →